Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 6 (2009), Issue 5 (May)

1. Alcohol misuse and multiple sclerosis.
   Arch Phys Med Rehabil, 90(5): 842-8. [Abstract] [Full-text]
2. Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis.
   Am J Epidemiol, 169(10): 1260-6. [Abstract] [Full-text]
3. Antisaccade performance in patients with multiple sclerosis.
   Cortex, 45(7): 900-3. [Abstract] [Full-text]
4. Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis.
   J Immunol, 182(10): 6569-75. [Abstract] [Full-text]
5. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
   Proc Natl Acad Sci U S A, 106(18): 7542-7. [Abstract] [Full-text]
6. Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): comparison of particular subgroups of MS patients.
   Folia Microbiol (Praha), 54(2): 173-6. [Abstract] [Full-text]
7. Preactive lesions in multiple sclerosis.
   Curr Opin Neurol, 22(3): 207-13. [Abstract] [Full-text]
8. Multiple sclerosis and the major histocompatibility complex.
   Curr Opin Neurol, 22(3): 219-25. [Abstract] [Full-text]
9. Epstein-Barr virus and multiple sclerosis.
   Curr Opin Neurol, 22(3): 201-6. [Abstract] [Full-text]
10. Regeneration and repair in multiple sclerosis: the role of cell transplantation.
    Neurosci Lett, 456(3): 101-6. [Abstract] [Full-text]
11. Normal plasma antithrombin activity in patients with relapsing-remitting and secondary progressive multiple sclerosis.
    Clin Neurol Neurosurg, 111(5): 407-11. [Abstract] [Full-text]
12. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Neuroscientist, 15(3): 225-31. [Abstract] [Full-text]
13. Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
    J Neurol Neurosurg Psychiatry, 80(6): 679-82. [Abstract] [Full-text]
14. Parity and secondary progression in multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 80(6): 676-8. [Abstract] [Full-text]
15. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 80(6): 620-5. [Abstract] [Full-text]
16. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis.
    Lancet Neurol, 8(6): 545-59. [Abstract] [Full-text]
17. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Lancet Neurol, 8(6): 519-29. [Abstract] [Full-text]
18. Myelin regulates immune cell adhesion and motility.
    Exp Neurol, 217(2): 371-7. [Abstract] [Full-text]
19. Investigation of the neural correlates underlying action observation in multiple sclerosis patients.
    Exp Neurol, 217(2): 252-7. [Abstract] [Full-text]
20. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.
    Neurology, 72(20): 1760-5. [Abstract] [Full-text]
21. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.
    Proc Natl Acad Sci U S A, 106(20): 8302-7. [Abstract] [Full-text]
22. A functional application of the spacing effect to improve learning and memory in persons with multiple sclerosis.
    J Clin Exp Neuropsychol, 31(5): 513-22. [Abstract] [Full-text]
23. APOE 4 polymorphism results in early cognitive deficits in an EAE model.
    Biochem Biophys Res Commun, 384(4): 466-70. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.